As depicted in Fig. 4, the specific serine protease inhibitor AEBSF attenuated systemic inflammation, obesity, and insulin resistance in diabetic mice, probably by modulating insulin receptor and cytokine expression in VAD tissue. The gene discussed is INSR; the disease is obesity due to melanocortin 4 receptor deficiency.